Medicaldrafts

27 departments across 36 government medical colleges in Telangana are running without any teaching faculty, exposing a dangerous collapse behind the rapid expansion of MBBS seats. This crisis is not limited to Telangana. Across India, medical colleges face faculty shortages, widening the gap between infrastructure and academic quality and decreasing the credibility and value of MBBS degree.

NEET PG 2025 saw drastic cut off reduction leading to PG seats being allotted at negative and single/double digit marks out of 800 across India. The trend has sparked a nationwide debate on merit, reservation policy, falling standards in medical colleges, and the future quality of specialist doctors in India’s healthcare system.

A major medical fraud has surfaced in Rajasthan after SOG arrested two fake foreign made doctors for using forged FMGE certificates to obtain internships and registration through the Rajasthan Medical Council. With 73 more candidates under investigation, the scam raises serious concerns about patient safety, regulatory failure and the integrity of India’s healthcare system.

The Karnataka government has restricted private practice by government doctors to outpatient services only, banning private inpatient treatment. This 2026 order aims to prevent neglect of duties in government hospitals and strengthen public healthcare accountability. A detailed medico legal analysis of the policy, its legal implications, and impact on specialists and private hospitals.

The Tamil Nadu Assistant Surgeon (General) Recruitment 2025 highlights India’s medical employment crisis, where 25,172 doctors competed for only 1100 government posts. With a 23:1 ratio, category wise seat fragmentation, repeated exams, and take home pay near ₹85,000, the notification exposes severe doctor overproduction and lack of workforce planning.

An in-depth analysis of medical examination of the accused in India under the Bharatiya Nagarik Suraksha Sanhita (BNSS), 2023. The article explains statutory powers, Supreme Court rulings, prohibition of potency tests, DNA and biometric evidence, custodial safeguards, and the ethical and legal boundaries doctors must follow in forensic examination practice.

Haryana’s 2025 medical officer recruitment has drawn nearly 12,000 MBBS graduates for just 450 posts. The overwhelming response highlights the growing gap between rising medical colleges and limited government jobs, falling pay, longer training periods, and increasing frustration among doctors across India’s healthcare system.

A first year MBBS student at MGM Medical College, Indore, was found dead in his hostel room, triggering shock and grief across the medical student community. The incident highlights the immense academic pressure, emotional stress, and mental health challenges faced by young medical students, especially during the early years of medical education in India.

FMGE 2025 results reveal a stark reality for foreign medical graduates in India. Only 23% candidates cleared the screening exam, leaving over 33,000 doctors without a license to practice. After spending 6–7 years studying medicine abroad, many remain unable to work, raising serious concerns about clinical training, curriculum gaps, and preparedness for Indian healthcare.

Madhya Pradesh plans to introduce Garbh Sanskar rooms in government hospitals in Indore under what is being described as the Abhimanyu Experiment. The initiative seeks to blend ancient beliefs about prenatal learning with modern public healthcare, raising important questions about science, tradition, and maternal responsibility in state run hospitals.

India’s Union Budget removes basic customs duty on 17 expensive cancer drugs including Ribociclib, Venetoclax and Ibrutinib. The move is expected to reduce treatment costs and improve access to life saving cancer therapies for Indian patients.

India’s Budget 2026 announces a ₹10,000 crore Biopharma SHAKTI push to boost domestic production of biologics and biosimilars. The policy aims to strengthen CDSCO regulation, expand NIPERs, and build clinical trial capacity, signalling India’s shift from generic medicines to high-value biopharmaceutical innovation.